§ 8-408. Protocol to offer opioid overdose reversal drugs
West's Annotated Code of MarylandHealth--GeneralEffective: July 1, 2022
Effective: July 1, 2022
MD Code, Health - General, § 8-408
§ 8-408. Protocol to offer opioid overdose reversal drugs
(b) On or before June 30, 2024, a community services program that provides services to individuals who have a substance use disorder or an opioid use disorder or are at risk of experiencing a drug overdose shall have a protocol to offer opioid overdose reversal drugs approved by the federal Food and Drug Administration, free of charge, to those individuals who have an opioid use disorder or are at risk of experiencing a drug overdose when the individual receives services from the community services program.
(c) On or before June 30, 2023, each opioid treatment program and each intensive outpatient treatment program shall have a protocol to offer an opioid overdose reversal drug approved by the federal Food and Drug Administration, free of charge, when an individual receives services from the opioid treatment program or intensive outpatient treatment program.
(d) On or before June 30, 2024:
(1) State and local correctional facilities shall have a protocol to offer an opioid overdose reversal drug approved by the federal Food and Drug Administration, free of charge, to sentenced individuals who have an opioid use disorder or who are at risk of experiencing a drug overdose before the individual's release; and
Credits
Added by Acts 2022, c. 239, § 1, eff. July 1, 2022.
MD Code, Health - General, § 8-408, MD HEALTH GEN § 8-408
Current through legislation effective through April 9, 2023, from the 2024 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
End of Document |